AGP Picks
View all

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on July 1, 2026

Rethink Food and Just Salad Roll Out Rethink Food Bowl for July
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA
Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
Abivax announces trading resumption of its ordinary shares on Euronext Paris
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury
QTREX Engineers Conductivity Itself to Address Quantum Computing’s Cryogenic Heat-Load Barrier
Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Human Appeal supports Syrian farmers through new wheat supply chain project
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Idaho Healthcare Hub

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.